Regeneron controller Pitofsky sells 4,062 shares
The sales included 179 shares held indirectly by the SVP Controller’s spouse, whose reported position was zero after the transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Regeneron Pharmaceuticals, Inc. (REGN) reports that SVP Controller Jason Pitofsky exercised non-qualified stock options on November 4, 2026, covering 905 shares at $492.00, 1,478 at $644.54 and 1,500 at $726.53; the report lists acquisitions of the corresponding common shares. It also records sales of 4,062 common shares at reported per-share prices ranging from $939.57 to $950.76, including 179 shares held indirectly by his spouse; the spouse-held position was zero afterward.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
14 txns
Insider
Pitofsky Jason
Role
SVP Controller
Sold
4,062 shs ($3.83M)
Approx. gross sale proceeds
$3.83M
Approx. exercise cost
$2.49M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F8 | 905 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F8 | 1,478 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F8 | 1,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,500 | $726.53 | $1.09M |
| Exercise | Common Stock | 1,478 | $644.54 | $953K |
| Exercise | Common Stock | 905 | $492.00 | $445K |
| Sale | Common Stock F1 | 439 | $939.57 | $412K |
| Sale | Common Stock F2 | 575 | $940.46 | $541K |
| Sale | Common Stock F3 | 982 | $941.58 | $925K |
| Sale | Common Stock F4 | 1,215 | $942.31 | $1.14M |
| Sale | Common Stock F5 | 529 | $943.53 | $499K |
| Sale | Common Stock F6 | 108 | $944.22 | $102K |
| Sale | Common Stock | 35 | $945.61 | $33K |
| Sale | Common Stock F7 | 179 | $950.76 | $170K |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 2,978 contracts (Direct);
Common Stock — 4,272 shares (Direct);
Common Stock — 0 shares (Indirect, by Spouse);
Common Stock — 48 shares (Indirect, By 401(k) Plan)
Footnotes (8)
- F1. Represents volume-weighted average price of sales of 439 shares of Company stock on November 4, 2026 at prices ranging from $939.10 to $939.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F2. Represents volume-weighted average price of sales of 575 shares of Company stock on November 4, 2026 at prices ranging from $940.15 to $940.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F3. Represents volume-weighted average price of sales of 982 shares of Company stock on November 4, 2026 at prices ranging from $941.08 to $941.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F4. Represents volume-weighted average price of sales of 1,215 shares of Company stock on November 4, 2026 at prices ranging from $942.00 to $942.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F5. Represents volume-weighted average price of sales of 529 shares of Company stock on November 4, 2026 at prices ranging from $943.00 to $943.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F6. Represents volume-weighted average price of sales of 108 shares of Company stock on November 4, 2026 at prices ranging from $944.00 to $944.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F7. Represents volume-weighted average price of sales of 179 shares of Company stock on November 4, 2026 at prices ranging from $950.45 to $950.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
- F8. The stock option award vested in four equal annual installments, commencing one year after the date of grant.
Key Figures
Options exercised: 905 shares at $492.00 per share
Options exercised: 1,478 shares at $644.54 per share
Options exercised: 1,500 shares at $726.53 per share
+4 more
7 metrics
Options exercised
905 shares at $492.00 per share
November 4, 2026
Options exercised
1,478 shares at $644.54 per share
November 4, 2026
Options exercised
1,500 shares at $726.53 per share
November 4, 2026
Common shares sold
4,062 shares
November 4, 2026
Spouse-held shares sold
179 shares at $950.76 per share
Weighted average sale price on November 4, 2026
Spouse-held common-stock position after sale
0 shares
November 4, 2026
401(k) Plan common-stock holding
48 shares
Indirect holding reported on November 4, 2026
Key Terms
Non-Qualified Stock Option, volume-weighted average price, 401(k) Plan
3 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
volume-weighted average price financial
"volume-weighted average price of sales of 439 shares"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
401(k) Plan financial
"By 401(k) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many REGN options did Jason Pitofsky exercise, and at what prices?
On November 4, 2026, SVP Controller Jason Pitofsky exercised options covering 905 shares at $492.00, 1,478 shares at $644.54 and 1,500 shares at $726.53. The report lists acquisitions of the corresponding numbers of common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
